Indian Stocks signal
MAXHEALTH

MAXHEALTH

Max Healthcare Institute Limited · Healthcare

Indian StocksMedical Care FacilitiesNSIINR-21.2% from ATH
Current Price

$1,024.10

Drawdown from ATH

-21.2%

Last Updated

Jun 17, 2026

Dipsern Grade90d

D

Weak

Graded against MAXHEALTH's own history at this drawdown — not the market's.

What it means: MAXHEALTH's own history does not strongly favor buying at this level yet.

What to do: Consider watching and waiting for a deeper dip or a higher grade.

Median 90-Day Return
Historical Win Rate
Last 30 days+0.81%
May 6Jun 16
About MAXHEALTH

Max Healthcare Institute Limited

Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive surgery, and organ transplants, as well as ear, nose, and throat. The company also provides Max@Home,

The reading

How Dipsern reads MAXHEALTH right now.

Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.

Snapshot

How is MAXHEALTH doing right now?

In plain terms: MAXHEALTH is 21.2% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.

As of the latest market close, Max Healthcare Institute Ltd. (MAXHEALTH) is trading in a deep drawdown, 21.2% below its all-time high at $1,024.1. Asset price action of this severity has historically marked attractive entry zones — but only when fundamentals weren't permanently impaired. The historical median return below quantifies that pattern for MAXHEALTH specifically.

Historical base rate

What history says at this drawdown

Across all available history, MAXHEALTH has spent enough trading days in the 25%-to-20% drawdown band to build a meaningful sample (52 observations). Dipsern segments these by drawdown depth and computes the rolling median forward 90-day return — that median is the primary signal you see in the full app, and it's substantially more robust than mean-based forecasts because it ignores fat-tail outliers in both directions.

Interpretation

What this means for MAXHEALTH

Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to MAXHEALTH's own volatility history. Below 20% drawdowns the historical median forward return often becomes attractive — but with rising variance. The win-rate column in the segments table is more useful than the median at this depth.

Comparable signals

Other Indian Stocks at similar drawdown levels

Five tickers closest to MAXHEALTH's distance from all-time high. Same category, one tap away.

Hindustan Zinc Ltd.

-21.3% from ATH

GAIL (India) Ltd.

-21.3% from ATH

ICICI Lombard General Insurance Co. Ltd.

-20.8% from ATH

Maruti Suzuki India Ltd.

-20.8% from ATH

The Indian Hotels Company Ltd.

-21.7% from ATH

Historical depth

Sample sizes by drawdown band

Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for MAXHEALTH. Median forward returns, win rates, and prediction errors are available in the full analysis.

Drawdown BandObservationsMedian ReturnWin Rate
-30% to -25%6
-25% to -20%Current52
-20% to -15%218
-15% to -10%211
-10% to -5%374
-5% to 0%520
Methodology

Every grade is reproducible.

We segment 40+ years of MAXHEALTH's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.

Years of history

40+

Drawdown bands

20

Look-ahead bias

None

Data sources

4

Unlock MAXHEALTH's full analysis

See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for MAXHEALTH.

Dipsern is research and a second opinion — not a broker. You'd buy MAXHEALTH at your own broker.

Analyze MAXHEALTH Free

No credit card required · 5 free analyses per month

Signal computed Jun 17, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.